Genetic heterogeneity and tissue-specific patterns of tumors with multiple PIK3CA mutations.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Sivakumar, Smruthy S; Jin, Dexter X DX; Rathod, Ruchita R; Ross, Jeffrey J; Cantley, Lewis C LC; Scaltriti, Maurizio M; Chen, Jessica W JW; Hutchinson, Katherine E KE; Wilson, Timothy R TR; Sokol, Ethan S ES; Vasan, Neil N
Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER-targeted therapy in HER2 amplification-positive and HER2 mutation-positive amplification-negative patients.
Genetic markers and phosphoprotein forms of beta-catenin pβ-Cat552 and pβ-Cat675 are prognostic biomarkers of cervical cancer.
Ebiomedicine
Scholl, Suzy M SM; Beal, Jonas J; de Koning, Leanne L; Girard, Elodie E; Popovic, Marina M; de la Rochefordière, Anne A; Lecuru, Fabrice F; Fourchotte, Virginie V; Ngo, Charlotte C; Floquet, Anne A; Berns, Els Mjj EM; Kenter, Gemma G; Gestraud, Pierre P; von der Leyen, Heiko H; Lecerf, Charlotte C; Puard, Vincent V; Roman, Sergio Roman SR; Latouche, Aurelien A; Kereszt, Attila A; Balint, Balazs B; Rouzier, Roman R; Kamal, Maud M
Publication Date: 2020-11
Variant appearance in text: PIK3CA: 1645G>C; D549H
Phase and context shape the function of composite oncogenic mutations.
Nature
Gorelick, Alexander N AN; Sánchez-Rivera, Francisco J FJ; Cai, Yanyan Y; Bielski, Craig M CM; Biederstedt, Evan E; Jonsson, Philip P; Richards, Allison L AL; Vasan, Neil N; Penson, Alexander V AV; Friedman, Noah D ND; Ho, Yu-Jui YJ; Baslan, Timour T; Bandlamudi, Chaitanya C; Scaltriti, Maurizio M; Schultz, Nikolaus N; Lowe, Scott W SW; Reznik, Ed E; Taylor, Barry S BS
Distinctive mutational spectrum and karyotype disruption in long-term cisplatin-treated urothelial carcinoma cell lines.
Scientific Reports
Skowron, Margaretha A MA; Petzsch, Patrick P; Hardt, Karin K; Wagner, Nicholas N; Beier, Manfred M; Stepanow, Stefanie S; Drechsler, Matthias M; Rieder, Harald H; Köhrer, Karl K; Niegisch, Günter G; Hoffmann, Michèle J MJ; Schulz, Wolfgang A WA
PIK3CA mutations are frequent in esophageal squamous cell carcinoma associated with chagasic megaesophagus and are associated with a worse patient outcome.
Infectious Agents And Cancer
Munari, Fernanda Franco FF; Cruvinel-Carloni, Adriana A; Lacerda, Croider Franco CF; de Oliveira, Antônio Talvane Torres ATT; Scapulatempo-Neto, Cristovam C; da Silva, Sandra Regina Morini SRM; Crema, Eduardo E; Adad, Sheila Jorge SJ; Rodrigues, Maria Aparecida Marchesan MAM; Henry, Maria Aparecida Coelho Arruda MACA; Guimarães, Denise Peixoto DP; Longatto-Filho, Adhemar A; Reis, Rui Manuel RM
Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.
Plos One
de Leng, Wendy W J WW; Gadellaa-van Hooijdonk, Christa G CG; Barendregt-Smouter, Françoise A S FA; Koudijs, Marco J MJ; Nijman, Ies I; Hinrichs, John W J JW; Cuppen, Edwin E; van Lieshout, Stef S; Loberg, Robert D RD; de Jonge, Maja M; Voest, Emile E EE; de Weger, Roel A RA; Steeghs, Neeltje N; Langenberg, Marlies H G MH; Sleijfer, Stefan S; Willems, Stefan M SM; Lolkema, Martijn P MP
Genome Analysis of Latin American Cervical Cancer: Frequent Activation of the PIK3CA Pathway.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Lou, Hong H; Villagran, Guillermo G; Boland, Joseph F JF; Im, Kate M KM; Polo, Sarita S; Zhou, Weiyin W; Odey, Ushie U; Juárez-Torres, Eligia E; Medina-Martínez, Ingrid I; Roman-Basaure, Edgar E; Mitchell, Jason J; Roberson, David D; Sawitzke, Julie J; Garland, Lisa L; Rodríguez-Herrera, Maria M; Wells, David D; Troyer, Jennifer J; Pinto, Francisco Castillo FC; Bass, Sara S; Zhang, Xijun X; Castillo, Miriam M; Gold, Bert B; Morales, Hesler H; Yeager, Meredith M; Berumen, Jaime J; Alvirez, Enrique E; Gharzouzi, Eduardo E; Dean, Michael M
PIK3CA mutations in advanced cancers: characteristics and outcomes.
Oncotarget
Janku, Filip F; Wheler, Jennifer J JJ; Naing, Aung A; Stepanek, Vanda M VM; Falchook, Gerald S GS; Fu, Siqing S; Garrido-Laguna, Ignacio I; Tsimberidou, Apostolia M AM; Piha-Paul, Sarina A SA; Moulder, Stacy L SL; Lee, Jack J JJ; Luthra, Rajyalakshmi R; Hong, David S DS; Kurzrock, Razelle R
PIK3CA mutation H1047R is associated with response to PI3K/AKT/mTOR signaling pathway inhibitors in early-phase clinical trials.
Cancer Research
Janku, Filip F; Wheler, Jennifer J JJ; Naing, Aung A; Falchook, Gerald S GS; Hong, David S DS; Stepanek, Vanda M VM; Fu, Siqing S; Piha-Paul, Sarina A SA; Lee, J Jack JJ; Luthra, Rajyalakshmi R; Tsimberidou, Apostolia M AM; Kurzrock, Razelle R
PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations.
Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology
Janku, Filip F; Wheler, Jennifer J JJ; Westin, Shannon N SN; Moulder, Stacy L SL; Naing, Aung A; Tsimberidou, Apostolia M AM; Fu, Siqing S; Falchook, Gerald S GS; Hong, David S DS; Garrido-Laguna, Ignacio I; Luthra, Rajyalakshmi R; Lee, J Jack JJ; Lu, Karen H KH; Kurzrock, Razelle R